labetalol has been researched along with Fetal Death in 7 studies
Labetalol: A salicylamide derivative that is a non-cardioselective blocker of BETA-ADRENERGIC RECEPTORS and ALPHA-1 ADRENERGIC RECEPTORS.
labetalol : A diastereoisomeric mixture of approximately equal amounts of all four possible stereoisomers ((R,S)-labetolol, (S,R)-labetolol, (S,S)-labetalol and (R,R)-labetalol). It is an adrenergic antagonist used to treat high blood pressure.
2-hydroxy-5-{1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl}benzamide : A member of the class of benzamides that is benzamide substituted by a hydroxy group at position 2 and by a 1-hydroxy-2-[(4-phenylbutan-2-yl)amino]ethyl group at position 5.
Fetal Death: Death of the developing young in utero. BIRTH of a dead FETUS is STILLBIRTH.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Labetalol was compared with methyldopa in a randomized controlled trial involving 176 pregnant women with mild to moderate hypertension." | 9.06 | Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. ( Breart, G; Maillard, F; Papiernik, E; Plouin, PF; Relier, JP, 1988) |
| "Hypotension is more common after maternal labetalol exposure, regardless of the dosage and route of administration." | 5.38 | Neonatal side effects of maternal labetalol treatment in severe preeclampsia. ( Heida, KY; Hulzebos, CV; Van Veen, TR; Zeeman, GG, 2012) |
| "Labetalol was compared with methyldopa in a randomized controlled trial involving 176 pregnant women with mild to moderate hypertension." | 5.06 | Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial. ( Breart, G; Maillard, F; Papiernik, E; Plouin, PF; Relier, JP, 1988) |
| "Hypotension is more common after maternal labetalol exposure, regardless of the dosage and route of administration." | 1.38 | Neonatal side effects of maternal labetalol treatment in severe preeclampsia. ( Heida, KY; Hulzebos, CV; Van Veen, TR; Zeeman, GG, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (28.57) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdel-Hady, el-S | 1 |
| Fawzy, M | 1 |
| El-Negeri, M | 1 |
| Nezar, M | 1 |
| Ragab, A | 1 |
| Helal, AS | 1 |
| Heida, KY | 1 |
| Zeeman, GG | 1 |
| Van Veen, TR | 1 |
| Hulzebos, CV | 1 |
| Hurst, JA | 1 |
| Houlston, RS | 1 |
| Roberts, A | 1 |
| Gould, SJ | 1 |
| Tingey, WG | 1 |
| Hussein, M | 1 |
| Mooij, JM | 1 |
| Roujouleh, H | 1 |
| Olsen, KS | 1 |
| Beier-Holgersen, R | 1 |
| Chimura, T | 1 |
| Plouin, PF | 1 |
| Breart, G | 1 |
| Maillard, F | 1 |
| Papiernik, E | 1 |
| Relier, JP | 1 |
1 trial available for labetalol and Fetal Death
| Article | Year |
|---|---|
Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial.
Topics: Adult; Clinical Trials as Topic; Female; Fetal Death; Fetus; Hemodynamics; Humans; Hypertension; Inf | 1988 |
6 other studies available for labetalol and Fetal Death
| Article | Year |
|---|---|
Is expectant management of early-onset severe preeclampsia worthwhile in low-resource settings?
Topics: Adolescent; Adult; Antihypertensive Agents; Egypt; Female; Fetal Death; Fetal Monitoring; Gestationa | 2010 |
Neonatal side effects of maternal labetalol treatment in severe preeclampsia.
Topics: Adult; Antihypertensive Agents; Case-Control Studies; Female; Fetal Death; Humans; Infant Mortality; | 2012 |
Transverse limb deficiency, facial clefting and hypoxic renal damage: an association with treatment of maternal hypertension?
Topics: Abnormalities, Drug-Induced; Adult; Child, Preschool; Facial Bones; Female; Fetal Death; Fetus; Huma | 1995 |
Factor analysis, including antihypertensive medication, of the outcome of pregnancy in pregnancy-associated hypertension.
Topics: Antihypertensive Agents; Apgar Score; Cesarean Section; Comorbidity; Disease Susceptibility; Female; | 2001 |
Fetal death following labetalol administration in pre-eclampsia.
Topics: Adult; Cesarean Section; Female; Fetal Death; Humans; Labetalol; Pre-Eclampsia; Pregnancy; Premedica | 1992 |
[Effects of beta-adrenoceptor blockade on parturition and fetal cardiovascular and metabolic system].
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Glucose; Ethanolamines; Female; Fetal Death; | 1985 |